Literature DB >> 15280410

Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma.

L Messerini1, L Novelli, C E Comin.   

Abstract

AIMS: To compare intratumorous microvessel density (MVD) and clinicopathological features in two different groups of hepatocellular carcinoma (HCC), namely: hepatitis B virus (HBV) related HCC (B-HCC) and HCV related HCC (C-HCC).
METHODS: Fifty consecutive cases each of B-HCC and of C-HCC were studied. Microvessel numbers were assessed by staining for the antigen CD34; in each case, three areas with the highest numbers of microvessels were counted in both the intratumorous and the surrounding non-tumorous tissue; the mean value represented the final MVD.
RESULTS: Patients with B-HCC were significantly younger than those with C-HCC (mean age, 60.1 (SD, 4.1) v 66.4 (4.3) years); no significant differences were seen for sex or Child's class distribution. The tumour diameter was larger in B-HCCs than in C-HCCs (mean, 5.6 (SD, 1.8) v 3.8 (1.8) cm). Tumour microsatellite formation was significantly higher in C-HCCs (12 v 4 cases). No differences were found for histological subtype, degree of differentiation, tumour encapsulation, and vascular invasion. The mean MVD value was significantly higher in tumorous (mean, 54 (SD, 13.8) v 38 (8.9)) and in the surrounding non-tumorous liver tissue (mean, 15 (SD, 4.3) v 7 (3.1)) of C-HCCs.
CONCLUSIONS: C-HCCs present as smaller tumours in older patients, with a higher incidence of tumour microsatellite formation and higher MVD values both in the tumorous and the non-tumorous areas, suggesting a link between HCV infection, angiogenesis, and hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280410      PMCID: PMC1770375          DOI: 10.1136/jcp.2003.015784

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver.

Authors:  Y N Park; C P Yang; G J Fernandez; O Cubukcu; S N Thung; N D Theise
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

3.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.

Authors:  K Moriya; H Fujie; Y Shintani; H Yotsuyanagi; T Tsutsumi; K Ishibashi; Y Matsuura; S Kimura; T Miyamura; K Koike
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

4.  Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis.

Authors:  R Mazzanti; L Messerini; L Monsacchi; G Buzzelli; A L Zignego; M Foschi; M Monti; G Laffi; L Morbidelli; O Fantappié; F Bartoloni Saint Omer; M Ziche
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

5.  Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.

Authors:  A Yamamoto; D K Dhar; O N El-Assal; M Igarashi; H Tabara; N Nagasue
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

6.  Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.

Authors:  U Dutta; J Kench; K Byth; M H Khan; R Lin; C Liddle; G C Farrell
Journal:  Hum Pathol       Date:  1998-11       Impact factor: 3.466

7.  Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.

Authors:  O N El-Assal; A Yamanoi; Y Soda; M Yamaguchi; M Igarashi; A Yamamoto; T Nabika; N Nagasue
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

8.  Differences of resected hepatocellular carcinoma with hepatitis B or C virus.

Authors:  T Shuto; K Hirohashi; S Kubo; T Tsukamoto; T Yamamoto; K Wakasa; H Kinoshita
Journal:  Hepatogastroenterology       Date:  1998 Sep-Oct

9.  Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.

Authors:  N Tanigawa; C Lu; T Mitsui; S Miura
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

10.  Characteristics of hepatocellular carcinoma in Italy.

Authors:  T Stroffolini; P Andreone; A Andriulli; A Ascione; A Craxi; M Chiaramonte; D Galante; O G Manghisi; R Mazzanti; C Medaglia; G Pilleri; G L Rapaccini; R G Simonetti; G Taliani; M E Tosti; E Villa; G Gasbarrini
Journal:  J Hepatol       Date:  1998-12       Impact factor: 25.083

View more
  24 in total

1.  Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma.

Authors:  Amr Mohamed; Avantika Chenna; Mohamed Abdelfatah; Jain Sanjay; M K Mohammad; Ibrahim Saber; John Kauh; Balsam Elhammali; Ahmed Kaseb
Journal:  J Gastrointest Cancer       Date:  2015-06

Review 2.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

3.  Angiogenesis: a phenomenon which aggravates chronic liver disease progression.

Authors:  Michał Kukla
Journal:  Hepatol Int       Date:  2012-07-26       Impact factor: 6.047

4.  New agents on the horizon in hepatocellular carcinoma.

Authors:  Andrew X Zhu
Journal:  Ther Adv Med Oncol       Date:  2013-01       Impact factor: 8.168

Review 5.  Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Authors:  Gar-Yang Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 6.  Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patients.

Authors:  Rodolfo Sacco; Valeria Mismas; Antonio Romano; Marco Bertini; Michele Bertoni; Graziana Federici; Salvatore Metrangolo; Giuseppe Parisi; Emanuele Tumino; Giampaolo Bresci; Luca Giacomelli; Sara Marceglia; Irene Bargellini
Journal:  World J Hepatol       Date:  2015-01-27

7.  Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.

Authors:  Yun-feng Shan; Yuan-lan Huang; Yuan-kang Xie; Yan-he Tan; Bi-Cheng Chen; Men-tao Zhou; Hong-qi Shi; Zheng-ping Yu; Qi-tong Song; Qi-yu Zhang
Journal:  Med Oncol       Date:  2010-06-23       Impact factor: 3.064

Review 8.  Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib.

Authors:  D Germano; V Tinessa; E Barletta; L Cannella; B Daniele
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

9.  Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.

Authors:  Ivan Chebib; Meer Taher Shabani-Rad; Michelle S Chow; James Zhang; Zu-Hua Gao
Journal:  Biomark Insights       Date:  2007-02-14

Review 10.  Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies.

Authors:  Andrew X Zhu; Dan G Duda; Dushyant V Sahani; Rakesh K Jain
Journal:  Cancer J       Date:  2009 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.